It can be speculated that a more reasonable explanation for this phenomenon is that, under hypoxic conditions, a subgroup of cancer cells expressing high levels of HIF-1α lose their hormone sensitivity and selectively survive after primary endocrine therapy. The gene discussed is HIF1A; the disease is cancer.